Login

Journal Image
Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
ISSN (Print): 1871-5206
ISSN (Online): 1875-5992
Epub Full Text Article
DOI: 10.2174/18715206113139990087      Price:  $95









Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer

img
Author(s): M.J. Molina-Garrido, C. Guillen-Ponce and A. Mora-Rufete
Abstract:
Trastuzumab or lapatinib treatment with chemotherapy or hormonotherapy are the gold standard treatments for human epidermal growth factor receptor 2 (HER2)-positive breast cancer (early breast cancer or metastatic breast cancer). Older patients have been largely underrepresented in clinical trials, and few data on trastuzumab or lapatinib efficacy and toxicity have been reported for this subgroup. This article has reviewed the main articles that have analyzed these items.
Keywords:
Adjuvant, Online, aging, anit-HER2 therapy, breast cancer, cardiotoxicity, chemotherapy, comorbidity, Comprehensive Geriatric Assessment, elderly women, histology, HER2 positive, lapatinib, St Gallen criteria, targeted therapy, trastuzumab
Affiliation:
Consulta de Cáncer en el Anciano, Sección de Oncología Médica, Hospital General Virgen de la Luz in Cuenca, Hermandad Donantes de Sangre Street, Cuenca, Spain